Cargando…
The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer
Prostate cancer (PCa) is one of the most common types of malignant tumor, which places a major burden on the health of men, worldwide. A prerequisite to ensure good treatment outcomes for patients with PCa is an accurate diagnosis. The present study aimed to investigate the diagnostic value of prost...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377033/ https://www.ncbi.nlm.nih.gov/pubmed/32724384 http://dx.doi.org/10.3892/ol.2020.11658 |
_version_ | 1783562143807832064 |
---|---|
author | Yang, Daijun Shi, Xiang Lei, Yu Zhou, Xianrong Chen, Qiuxiang |
author_facet | Yang, Daijun Shi, Xiang Lei, Yu Zhou, Xianrong Chen, Qiuxiang |
author_sort | Yang, Daijun |
collection | PubMed |
description | Prostate cancer (PCa) is one of the most common types of malignant tumor, which places a major burden on the health of men, worldwide. A prerequisite to ensure good treatment outcomes for patients with PCa is an accurate diagnosis. The present study aimed to investigate the diagnostic value of prostate-specific antigen (PSA) and α-methylacyl-CoA racemase (P504S) in PCa, using the tumor-associated immunolabels. In total, clinical data was collected from 125 patients undergoing prostate biopsy or surgery between January 2015 and September 2019, and stratified into: PCa (45), benign prostatic hyperplasia (BPH) (60) and unconfirmed diagnosis (20). Immunohistochemistry analysis was performed to assess PSA and P504S expression levels in each group compared with that in the controls (the normal tissue in each group was the internal control). The results demonstrated that the expression level of P504S was significantly higher in the PCa group compared with that in the BPH group. Furthermore, no significant association was observed in the PCa group between PSA and P504S expression levels, and the Gleason grading groups. A total of 20 unconfirmed diagnoses was verified via PSA/P504S. Taken together, the results suggest that combination PSA and P504S have a positive effect in identifying prostate cancer. However, PSA and P504S still have limitations in their diagnosis and the final results need to be carefully and comprehensively analyzed, thus further studies are required to determine their diagnostic values. |
format | Online Article Text |
id | pubmed-7377033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-73770332020-07-27 The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer Yang, Daijun Shi, Xiang Lei, Yu Zhou, Xianrong Chen, Qiuxiang Oncol Lett Articles Prostate cancer (PCa) is one of the most common types of malignant tumor, which places a major burden on the health of men, worldwide. A prerequisite to ensure good treatment outcomes for patients with PCa is an accurate diagnosis. The present study aimed to investigate the diagnostic value of prostate-specific antigen (PSA) and α-methylacyl-CoA racemase (P504S) in PCa, using the tumor-associated immunolabels. In total, clinical data was collected from 125 patients undergoing prostate biopsy or surgery between January 2015 and September 2019, and stratified into: PCa (45), benign prostatic hyperplasia (BPH) (60) and unconfirmed diagnosis (20). Immunohistochemistry analysis was performed to assess PSA and P504S expression levels in each group compared with that in the controls (the normal tissue in each group was the internal control). The results demonstrated that the expression level of P504S was significantly higher in the PCa group compared with that in the BPH group. Furthermore, no significant association was observed in the PCa group between PSA and P504S expression levels, and the Gleason grading groups. A total of 20 unconfirmed diagnoses was verified via PSA/P504S. Taken together, the results suggest that combination PSA and P504S have a positive effect in identifying prostate cancer. However, PSA and P504S still have limitations in their diagnosis and the final results need to be carefully and comprehensively analyzed, thus further studies are required to determine their diagnostic values. D.A. Spandidos 2020-08 2020-05-21 /pmc/articles/PMC7377033/ /pubmed/32724384 http://dx.doi.org/10.3892/ol.2020.11658 Text en Copyright: © Yang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Yang, Daijun Shi, Xiang Lei, Yu Zhou, Xianrong Chen, Qiuxiang The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer |
title | The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer |
title_full | The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer |
title_fullStr | The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer |
title_full_unstemmed | The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer |
title_short | The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer |
title_sort | auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-coa racemase in prostate cancer |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377033/ https://www.ncbi.nlm.nih.gov/pubmed/32724384 http://dx.doi.org/10.3892/ol.2020.11658 |
work_keys_str_mv | AT yangdaijun theauxiliarydiagnosticvalueofprostatespecificantigenandamethylacylcoaracemaseinprostatecancer AT shixiang theauxiliarydiagnosticvalueofprostatespecificantigenandamethylacylcoaracemaseinprostatecancer AT leiyu theauxiliarydiagnosticvalueofprostatespecificantigenandamethylacylcoaracemaseinprostatecancer AT zhouxianrong theauxiliarydiagnosticvalueofprostatespecificantigenandamethylacylcoaracemaseinprostatecancer AT chenqiuxiang theauxiliarydiagnosticvalueofprostatespecificantigenandamethylacylcoaracemaseinprostatecancer AT yangdaijun auxiliarydiagnosticvalueofprostatespecificantigenandamethylacylcoaracemaseinprostatecancer AT shixiang auxiliarydiagnosticvalueofprostatespecificantigenandamethylacylcoaracemaseinprostatecancer AT leiyu auxiliarydiagnosticvalueofprostatespecificantigenandamethylacylcoaracemaseinprostatecancer AT zhouxianrong auxiliarydiagnosticvalueofprostatespecificantigenandamethylacylcoaracemaseinprostatecancer AT chenqiuxiang auxiliarydiagnosticvalueofprostatespecificantigenandamethylacylcoaracemaseinprostatecancer |